Basit öğe kaydını göster

Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)

dc.contributor.authorYoldaş İlktaç, Havvanur
dc.contributor.authorKızıltan, Gül
dc.contributor.authorDevrim Lanpir, Aslı
dc.contributor.authorOzansoy, Mehmet
dc.contributor.authorGünal, Mehmet Yalçın
dc.contributor.authorÖzmen Toğay, Sine
dc.contributor.authorKeskin, İlknur
dc.contributor.authorÖzdemir, Ekrem Musa
dc.contributor.authorKılıç, Ülkan
dc.date.accessioned2022-05-27T09:15:14Z
dc.date.available2022-05-27T09:15:14Z
dc.date.issued2022en_US
dc.identifier.citationYoldaş İlktaç, H., Kızıltan, G., Devrim Lanpir, A., Ozansoy, M., Günal, M. Y., Özmen Toğay, S. ... Kılıç, Ü. (2022). Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021). Folia Biologica-Krakow, 70(1), 43-43. https://doi.org/10.3409/fb_70-1.05en_US
dc.identifier.issn0015-5497
dc.identifier.issn1734-9168
dc.identifier.urihttps://doi.org/10.3409/fb_70-1.05
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9474
dc.description.abstractWe published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused.en_US
dc.language.isoengen_US
dc.publisherPolish Academy of Sciencesen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectOmega-3en_US
dc.subjectVSL#3en_US
dc.subjectFatty Acidsen_US
dc.subjectDNBS-Induced Colitisen_US
dc.titleCombined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice (vol 69, pg 135, 2021)en_US
dc.title.alternativeCorrigendum to: Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic ınjury and ınflammation in Chronic DNBS-induced colitis in miceen_US
dc.typeotheren_US
dc.relation.ispartofFolia Biologica-Krakowen_US
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Tıbbi Araştırma Merkezi (MEDİTAM)en_US
dc.authorid0000-0001-9416-7757en_US
dc.identifier.volume70en_US
dc.identifier.issue1en_US
dc.identifier.startpage43en_US
dc.identifier.endpage43en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.3409/fb_70-1.05en_US
dc.institutionauthorÖzdemir, Ekrem Musa
dc.identifier.wosqualityQ4en_US
dc.identifier.wos000792884400005en_US
dc.identifier.scopus2-s2.0-85130591657en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
Ozdemir-Ekrem-2022.pdf
Boyut:
43.75Kb
Biçim:
PDF
Açıklama:
Tam Metin / Full Text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster